Roche (OTCMKTS:RHHBY) Sets New 52-Week High – Still a Buy?

Roche Holding AG (OTCMKTS:RHHBY) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $53.90 and last traded at $53.20, with a volume of 3080095 shares changing hands. The stock had previously closed at $53.40.

Analysts Set New Price Targets

A number of analysts have commented on RHHBY shares. Jefferies Financial Group downgraded Roche from a “hold” rating to a “moderate sell” rating in a research report on Monday, October 27th. JPMorgan Chase & Co. raised Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th. Zacks Research raised shares of Roche from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Barclays raised shares of Roche from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Roche from a “sell” rating to a “hold” rating in a research note on Tuesday, November 11th. Three equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $57.00.

Roche Stock Performance

The company has a quick ratio of 1.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.80. The company’s 50 day moving average price is $48.94 and its 200 day moving average price is $44.01.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of RHHBY. Rhumbline Advisers raised its holdings in shares of Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after buying an additional 7,374 shares during the last quarter. OLD National Bancorp IN raised its stake in shares of Roche by 2.9% in the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after acquiring an additional 7,326 shares during the last quarter. Enterprise Financial Services Corp bought a new position in shares of Roche in the second quarter worth about $208,000. North Star Asset Management Inc. lifted its position in shares of Roche by 52.0% during the second quarter. North Star Asset Management Inc. now owns 26,305 shares of the company’s stock worth $1,072,000 after purchasing an additional 9,000 shares in the last quarter. Finally, FineMark National Bank & Trust bought a new stake in shares of Roche during the second quarter valued at approximately $210,000.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.